This Author published in this journals
All Journal JFIOnline
Lestiono, .
Dep. Farmasi Rumkital Dr. Ramelan Surabaya

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

PENGGUNAAN OBAT PADA PASIEN SIROSIS HEPATIK ENSEFALOPATI DI RUMKITAL Dr. RAMELAN SURABAYA Suharjono, .; Rusdiana, Silvia; Lestiono, .; Bagiyo, Harry
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol 5, No 1 (2010)
Publisher : Indonesian Research Gateway

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Hepatic Encephalopathy  is a neuropsychiatric disorder that occurs due to liver damage, especially in  such as cirrhosis hepatic. Most cases of HE are caused by toxic substances such as ammonia. The aim of this study was to identify the profile and pattern of drug use as for HE patients. A retrospective-prospective method was used with a descriptive analysis. Samples taken from October 2008-February 2009 for the retrospective (n = 9) and March 2008-June 2009 for prospective (n = 15) in Room A1, A2, B1 and B2 Department of Internal Medicine Rumkital Dr. Ramelan.   Of 24 patients, 14 patients were male and 10 patients were female.The main therapeutic options for HE patients include parenteral nutrition of the BCAA that were given in 19 people (79.17%); flumazenil, levodopa, bromocriptine, L-ornithine-L-aspartate, citicholine, piracetam; antibiotics also was given such as kanamycin in 19 people (79.17%), neomycin 1 person (4.17%) and metronidazole 2 people (8:33%),  and 3rd generation cephalosporin ie ceftriaxone in 16 people (66.67%). and lactulose in 15 people (66.67%).   ABSTRAK Ensefalopati Hepatik (EH) adalah gangguan neuropsikiatrik yang terjadi karena kerusakan liver  terutama pada sirosis hepatic. Sebagian besar kasus EH disebabkan zat-zat toksik diantaranya ammonia. Tujuan penelitian untuk mengidentifikasi profil dan pola penggunaan obat sesuai indikasi pasien EH. Pada penelitian ini digunakan metode retrospektif-prospektif dengan analisis deskriptif. Sampel diambil pada Oktober 2008-Februari 2009 untuk retrospektif (n=9) dan Maret 2008-Juni 2009 untuk prospektif (n=15) di Ruang A1, A2, B1 dan B2 Departemen Penyakit Dalam dan ECU Rumkital Dr. Ramelan . Obat yang digunakan adalah parenteral nutrition , yaitu : BCAA 19 orang (79.17%), flumazenil, levodopa, bromokriptin, L-ornitin-L-aspartat, sitikolin, pirasetam. antibiotik yang diberikan dalam penelitian adalah kanamisin 19 orang  (79.17%), neomisin 1 orang (4.17 %) dan metronidazol 2 orang (8.33%). Antibiotik lain yang banyak digunakan yaitu seftriakson sebanyak 16 orang (66.67%). laktulosa digunakan pada 15 orang (66.67%).